Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Novel inhibitor of tyrosine kinases shows antitumor activity in preclinical models

April 24, 2008

Hsp90 inhibitors demonstrate antitumor effects in preclinical studies

April 24, 2008

Lorus Therapeutics to examine new administration route for LOR-2040

April 23, 2008

SNS-314 induces tumor growth inhibition in xenograft models

April 23, 2008

BMS-753493 cytotoxic in folate receptor-positive human tumor cells

April 23, 2008

Kosan demonstrates anticancer activity of CRM1-protein inhibition

April 23, 2008

Bayer launches Nexavar in Japan for recurrent renal carcinoma

April 22, 2008

Sutent approved in Japan for GIST and renal cell carcinoma

April 22, 2008

Thalidomide Pharmion granted E.U. marketing authorization for multiple myeloma

April 22, 2008

Preclinical activity of Aurora kinase B/C inhibitor GSK-1070916A described

April 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...